On Dec. 8, 2019, the accountant began to feel ill.
An earlier version of this article misstated the scientific journal that published a paper on wild animals at the Huanan market in Wuhan. The journal is Scientific Reports, not Nature. The article has been corrected.
He hadn’t traveled outside of Wuhan in the days before his illness. If someone caught the novel coronavirus by crawling in a bat cave, it wasn’t him.
In the search for the pandemic’s origin, the trail officially ends with Patient S01, China’s first confirmed covid-19 case, whose sparse details were outlined in the joint WHO-China report released in March. He was not a seafood vendor, bat hunter or lab scientist. He was an accountant surnamed Chen who shopped at a very large supermarket.
“We can actually say surprisingly little about the pandemic origin,” said Sergei Pond, a Temple University biology professor, who has been analyzing some of the earliest SARS-CoV-2 genetic sequences. “We are looking at very few sequences and trying to learn a lot about them.”
Even for S01, the most scrutinized patient, details are hazy. The WHO report lists a sample sequence ID for him, EPI_ISL_403928, that belongs to a different patient, a 61-year-old market worker who died of septic shock after falling ill on Dec. 20, 2019, according to the official China National Center for Bioinformation database.
S01’s profile matches better with that of a 41-year-old whose coronavirus diagnosis at the end of December alarmed doctors — prompting one whistleblower, Li Wenliang, to leak the news on social media. But that patient is listed in the Chinese database as falling ill on Dec. 16. A WHO spokesman said the U.N. agency is looking into the discrepancy.
That so little is confirmed is unsatisfying, but not necessarily surprising. Despite intense desire to understand the pandemic’s source, it often takes years for scientists to establish the provenance and early infection path of a new disease. And China’s government hasn’t made it easier, limiting access to biological samples and original records, even to the WHO.
Researchers have collected a handful of clues — in places as far-flung as Milan and Paris — that hint at what might have happened in the days before Patient S01 fell ill. Some of the data points are uncertain or contradictory, and scientists caution that new information could surface that wipes the slate clean.
For now, this is the hazy picture emerging.
Clues in Europe
Three days before Patient S01’s symptoms began, on Dec. 5, 2019, an oral swab was taken from a 4-year-old boy outside of Milan who was suspected of having measles. Months later, it tested positive for coronavirus RNA. The case, outlined in the Emerging Infectious Diseases journal, is one of several European studies suggesting the virus may have circulated undetected overseas for weeks, even months.
Researchers in France say they found hints of the virus even earlier, in November. A team from France’s National Institute for Health and Medical Research and other institutes retrospectively examined over 9,000 serum samples banked as part of a public health project from November 2019 through March 2020.
“We found antibodies in the first week of November, but we had no money to go back further in time,” said Marie Zins, the project’s scientific director. “It’s a shame, because in November, we had seven volunteers who were positive, including two in the first week of November.”
In their paper, Zins’s team acknowledged the possibility of false positives but said it was unlikely to be the case for all their positive results.
Then there is the most controversial study: In a paper published in November, researchers in Italy reported traces of the coronavirus in September 2019, declaring it may “reshape the history” of the pandemic. Scientists from the National Cancer Institute of Milan and the University of Siena analyzed nearly 1,000 blood samples collected in 2019 from a cancer-screening trial. They reported more than 10 percent containing coronavirus antibodies, including samples from September 2019.
The result was striking enough for the WHO to request retesting by a different laboratory, in the Netherlands. That retesting process is now complete, but the lab declined to provide details, and the WHO referred the matter back to the original Italian researchers. An author of the original study, Giovanni Apolone, the scientific director of the National Cancer Institute of Milan, indicated there was some disagreement about how to interpret the retest results, and said that his team was working on a new paper — one the Netherlands researchers “won’t be signing.”
“I can tell you from our viewpoint, the results are favorable to our original study but in a very complex scenario,” Apolone said.
Emanuele Montomoli, another co-author, theorized in an interview they might have detected a “less transmissible” strain that could circulate without sparking a major outbreak.
Some doctors doubt the virus could have circulated unnoticed for so long and say antibody tests can produce false positives.
Other research suggests small-scale earlier transmission was possible. In a paper published in Science magazine in April, scientists simulated a SARS-CoV-2 outbreak 1,000 times, and found it fizzled out more than two-thirds of the time. Joel Wertheim, an evolutionary biologist at the University of California at San Diego involved in the study, said their team estimated the Wuhan outbreak began in November but couldn’t rule out earlier isolated clusters.
Confirming how early patients were infected is difficult. Zins said the vast majority of those with antibodies in France had no confirmed links to China. One spent two months traveling through China but did not visit Wuhan.
Chinese officials have suggested that the virus was brought to Wuhan from abroad. This theory has found little support from scientists in other countries, partly because of the genetic similarity between SARS-CoV-2 and known bat coronaviruses from China’s south.
The Chinese Embassy in Washington said in a statement that origin study must follow the science and “can only be a joint scientific study.”
“Any action that politicizes origin-tracing poisons the atmosphere of scientific research, hampers global cooperation in this regard, and undermines global efforts to fight the virus,” it said.
In Wuhan, official searches for patients preceding Patient S01 have been unsuccessful, despite the Chinese government’s boasts in recent years of its high-tech surveillance capabilities. In the WHO report, it said local hospitals checked dozens of early suspected cases and all were negative.
At the origin
Wei Bing, a 32-year-old shop owner in Wuhan, says she doesn’t recall much out of the ordinary in autumn 2019. Wuhan hosted the Military World Games in October, an Olympics-like tournament for soldiers. The streets were extra clean, roadblocks erected around the Games sites.
“As a Wuhan resident, I was very proud,” she said.
Several scientific teams estimate the outbreak could have begun as early as October 2019. It would have been easy to miss the first cases: China was in the thick of its worst flu season in more than a decade. Official statistics show that by November 2019, there were five times the number of influenza cases across China compared to a year earlier. By December, it was ninefold.
Some U.S. lawmakers are calling for an investigation into potential coronavirus infections at the Military World Games. It was only one of a string of international events in Wuhan that autumn, each a potential path for a virus to seep overseas. With 11 million people, Wuhan has more residents than New York City.
German Chancellor Angela Merkel visited Wuhan in September 2019. In ensuing weeks, Wuhan hosted the Military World Games, Asia’s largest motor show, a global bridge-builders’ forum, an international material sciences gathering and a reunion of Peking University alumni. As late as Dec. 20, as clusters of seafood market workers fell ill, Alibaba founder Jack Ma and smartphone brand Xiaomi founder Lei Jun were in Wuhan for an economic conference.
There were early rumors. One Wuhan resident, Stella Zhou, recalled to The Washington Post that she heard talk of a mysterious pneumonia at a child-care center on Dec. 8, 2019, the same day Patient S01 fell ill, and nearly a month before the official announcement. Another resident, Zhu Wei, said some early cases probably went undiagnosed.
“Everyone around me has the feeling that the real number was far higher than the official count,” Zhu said. “At first, there were many who didn’t have a chance to get tested or couldn’t get medical treatment.”
The WHO report mentions earlier suspected patients but said they were not made available for interviews.
In their follow-up recommendations, the WHO experts called for a review of early blood samples from the Wuhan Blood Center and medical records from the Military World Games. The WHO did not reply to questions about whether these reviews took place. The Wuhan Blood Center, Wuhan CDC and Hubei province CDC did not respond to requests for comment.
For most of 2020, the earliest case was believed to be a Wuhan resident who fell ill on Dec. 1, 2019. This was revised in the WHO report: He was determined to have suffered other illness in early December, contracting the coronavirus later that month with his wife in a family cluster.
The revision turned the accountant surnamed Chen, with Dec. 8, 2019, symptom onset, into the official first case.
Chasing loose ends
By November 2019, the coronavirus had probably infected a small number of people in Wuhan, scientists say. The city bustled with activity, creating endless paths that a virus could travel.
On Nov. 2, a handful of Italian exchange students sat down at bright blue desks at a Wuhan university to try their hand at Chinese calligraphy. The next week, 2,000 people clad in “hanfu,” the flowing ancient Chinese robes, converged at the Yellow Crane Tower for a festival. Later in November, some 200,000 people, including visitors from 20 countries, toured an agricultural expo.
That month, a Chinese wildlife conservation scientist made a routine visit to the Huanan market he had tracked for two years and confirmed it was still selling wild animals in poor hygienic conditions, as his team later wrote in the Scientific Reports journal.
And on Nov. 19, 2019, the Wuhan Institute of Virology held an annual staff safety training session. Deputy director of security Hu Qian discussed safety problems found during audits over the past year, according to a post on the institute’s website.
The institute did not respond to questions on what kind of safety lapses were found in the audits. Its leadership has vehemently denied having encountered SARS-CoV-2 before the pandemic or the occurrence of any lab leaks.
The WHO report called the theory of a lab leak starting the pandemic “extremely unlikely.” A number of scientists have since said they believed it remained a possibility, including Jesse Bloom, a computational biologist at the Fred Hutchinson Cancer Research Center in Seattle.
“The origins of SARS-CoV-2 remain unclear, with the two plausible theories being a natural zoonosis or a lab accident,” Bloom said.
The origin search has been hobbled by scarce early information, some of it unreliable or missing.
The online archives of two local state-run newspapers, the Hubei Daily and Chutian Metro Daily, can no longer be accessed before Nov. 5, 2019, according to checks by The Post. The newspapers’ publisher did not respond to a request for comment.
Bloom made waves last month when he announced that he recovered 13 early coronavirus genetic sequences that had been deleted from a database by researchers in Wuhan for unknown reasons.
“As scientists, we need to find ways to obtain more data about the earliest cases,” he said.
Pond, the Temple University professor, says Bloom’s paper underscored just how little data exists on the early days of the pandemic. Those recovered sequences fill some gaps in their reconstruction of how the virus evolved, strengthening the theory that the Huanan market wasn’t the sole source of the outbreak, he said.
“Even as few as 13 new sequences, which if you think about it, is a tiny amount, can fairly substantially modify the understanding of the pandemic origin,” Pond said.
Alicia Chen, Stefano Pitrelli, Pei Lin Wu and Emily Rauhala contributed to this report.
Coronavirus: What you need to know
The latest: The CDC has loosened many of its recommendations for battling the coronavirus, a strategic shift that puts more of the onus on individuals, rather than on schools, businesses and other institutions, to limit viral spread.
Variants: BA.5 is the most recent omicron subvariant, and it’s quickly become the dominant strain in the U.S. Here’s what to know about it, and why vaccines may only offer limited protection.
Vaccines: Vaccines: The Centers for Disease Control and Prevention recommends that everyone age 12 and older get an updated coronavirus booster shot designed to target both the original virus and the omicron variant circulating now. You’re eligible for the shot if it has been at least two months since your initial vaccine or your last booster. An initial vaccine series for children under 5, meanwhile, became available this summer. Here’s what to know about how vaccine efficacy could be affected by your prior infections and booster history.
Guidance: CDC guidelines have been confusing — if you get covid, here’s how to tell when you’re no longer contagious. We’ve also created a guide to help you decide when to keep wearing face coverings.
For the latest news, sign up for our free newsletter.